Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma

Mateusz Opyrchal, Travis Figanbaum, Amit Ghosh, Vincent Rajkumar, Sean Caples

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Tumor lysis syndrome (TLS) presenting in absence of chemotherapy is a rare occurrence. One of the true oncological emergencies, it can lead to significant morbidity and mortality. TLS is a phenomena usually associated with tumor cell death after treatment. The etiology of the spontaneous TLS is not well understood, which complicates the diagnosis. TLS is well known to oncologists but physicians outside of this specialty have little or no experience with this condition. Early recognition and treatment are the keys to limiting the sequela of the condition. Spontaneous tumor lysis syndrome is rare but presents added risks to the patient because of the potential for delayed diagnosis and no benefit of pretreatment. Diagnosis may be further delayed because this may be the first symptom of underlying malignancy. Therefore, it is imperative that all clinicians are familiar with the syndrome to assure timely recognition.

Original languageEnglish (US)
Article number610969
JournalCase Reports in Medicine
StatePublished - 2010

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma'. Together they form a unique fingerprint.

Cite this